South & Central America Antibiotics & Antimycotics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. South & Central America Antibiotics & Antimycotics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. South & Central America Antibiotics & Antimycotics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. South & Central America Antibiotics & Antimycotics Market Regional Analysis

6.2 South & Central America Antibiotics & Antimycotics Market Revenue 2021-2031 (US$ Million)

6.3 South & Central America Antibiotics & Antimycotics Market Forecast Analysis

7. South & Central America Antibiotics & Antimycotics Market Analysis – by Drug Class

7.1 Penicillin

7.1.1 Overview
7.1.2 Penicillin: South & Central America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.2 Cephalosporines

7.2.1 Overview
7.2.2 Cephalosporines: South & Central America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.3 Carbapenems

7.3.1 Overview
7.3.2 Carbapenems: South & Central America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.4 Macrolides

7.4.1 Overview
7.4.2 Macrolides: South & Central America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.5 Aminoglycosides

7.5.1 Overview
7.5.2 Aminoglycosides: South & Central America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.6 Quinolones

7.6.1 Overview
7.6.2 Quinolones: South & Central America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.7 Sulfonamides

7.7.1 Overview
7.7.2 Sulfonamides: South & Central America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.8 Tetracyclines

7.8.1 Overview
7.8.2 Tetracyclines: South & Central America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.9 Azoles

7.9.1 Overview
7.9.2 Azoles: South & Central America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.10 Others

7.10.1 Overview
7.10.2 Others: South & Central America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. South & Central America Antibiotics & Antimycotics Market Analysis – by Indication

8.1 Skin Infections

8.1.1 Overview
8.1.2 Skin Infections: South & Central America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.2 Respiratory Infections

8.2.1 Overview
8.2.2 Respiratory Infections: South & Central America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.3 Urinary Tract Infections

8.3.1 Overview
8.3.2 Urinary Tract Infections: South & Central America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.4 Septicemia

8.4.1 Overview
8.4.2 Septicemia: South & Central America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.5 Ear Infections

8.5.1 Overview
8.5.2 Ear Infections: South & Central America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.6 Gastrointestinal Infections

8.6.1 Overview
8.6.2 Gastrointestinal Infections: South & Central America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.7 Others

8.7.1 Overview
8.7.2 Others: South & Central America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. South & Central America Antibiotics & Antimycotics Market Analysis – by Route Of Administration

9.1 Oral

9.1.1 Overview
9.1.2 Oral: South & Central America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.2 Topical

9.2.1 Overview
9.2.2 Topical: South & Central America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.3 Others

9.3.1 Overview
9.3.2 Others: South & Central America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. South & Central America Antibiotics & Antimycotics Market Analysis – by Distribution Channel

10.1 Hospital Pharmacies

10.1.1 Overview
10.1.2 Hospital Pharmacies: South & Central America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.2 Retail Pharmacies

10.2.1 Overview
10.2.2 Retail Pharmacies: South & Central America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.3 Online Pharmacies

10.3.1 Overview
10.3.2 Online Pharmacies: South & Central America Antibiotics & Antimycotics Market – Revenue and Forecast, 2021-2031 (US$ Million)

11. South & Central America Antibiotics & Antimycotics Market – South and Central America Analysis

11.1 Overview

11.2 South and Central America

11.2.1 South & Central America Antibiotics & Antimycotics Market Breakdown, by Key Country, 2024 and 2031 (%)
11.2.1.1 South & Central America Antibiotics & Antimycotics Market – Revenue and Forecast Analysis – by Country
11.2.1.1 Brazil: South & Central America Antibiotics & Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.1.1 Brazil: South & Central America Antibiotics & Antimycotics Market Breakdown, by Drug Class
11.2.1.1.2 Brazil: South & Central America Antibiotics & Antimycotics Market Breakdown, by Indication
11.2.1.1.3 Brazil: South & Central America Antibiotics & Antimycotics Market Breakdown, by Route Of Administration
11.2.1.1.4 Brazil: South & Central America Antibiotics & Antimycotics Market Breakdown, by Distribution Channel

11.2.1.2 Argentina: South & Central America Antibiotics & Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.2.1 Argentina: South & Central America Antibiotics & Antimycotics Market Breakdown, by Drug Class
11.2.1.2.2 Argentina: South & Central America Antibiotics & Antimycotics Market Breakdown, by Indication
11.2.1.2.3 Argentina: South & Central America Antibiotics & Antimycotics Market Breakdown, by Route Of Administration
11.2.1.2.4 Argentina: South & Central America Antibiotics & Antimycotics Market Breakdown, by Distribution Channel

11.2.1.3 Rest of South and Central America: South & Central America Antibiotics & Antimycotics Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.3.1 Rest of South and Central America: South & Central America Antibiotics & Antimycotics Market Breakdown, by Drug Class
11.2.1.3.2 Rest of South and Central America: South & Central America Antibiotics & Antimycotics Market Breakdown, by Indication
11.2.1.3.3 Rest of South and Central America: South & Central America Antibiotics & Antimycotics Market Breakdown, by Route Of Administration
11.2.1.3.4 Rest of South and Central America: South & Central America Antibiotics & Antimycotics Market Breakdown, by Distribution Channel

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Pfizer Inc

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Novartis AG

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Sanofi SA

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 F. Hoffmann-La Roche Ltd

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Merck & Co Inc

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 GSK Plc

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Johnson & Johnson

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Cipla Ltd

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Bayer AG

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 AbbVie Inc

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

14.11 Astellas Pharma Inc

14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

South & Central America Antibiotics & Antimycotics Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis